The Alliance’s webinar this week, “Patient Access at Risk – Real World Impact and Future Concerns About the IRA “Pill Penalty” provided engaging discussion on implications for the development of innovative patient care. Patient advocates and policy experts discuss new research on IRA impacts on small-molecule medicine development and the current legislative landscape.
The briefing elevates health advocacy perspectives on how the pill penalty threatens patient access and equitable care, and will provide opportunities for impactful advocacy. Speakers include:
- Congressman Don Davis (D-NC)
- Duane Schulthess, CEO, Vital Transformation
- Sally Werner, CEO, Cancer Support Community
- Peter Rubin, Executive Director, No Patient Left Behind
- John Stanford, Founder & Executive Director, Incubate Coalition
